Log In
Print this Print this

Bexxar, tositumomab

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionIodine-131 radiolabeled mAb targeted to CD20 antigen on B cells
Molecular Target CD20
Mechanism of ActionRadiolabelled antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today